logit choice model (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
logit choice model
Logit Choice Model, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 36686 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rank-ordered+logit+choice+model/STATA+1%2E0/pm38104119-174-8-12
Average 99 stars, based on 36686 article reviews
Logit Choice Model, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 36686 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rank-ordered+logit+choice+model/STATA+1%2E0/pm38104119-174-8-12
Average 99 stars, based on 36686 article reviews
logit choice model - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
other:Article Title: From simple to even simpler, but not too simple: a head-to-head comparison of the Better-Worse and Drop-Down methods for measuring patient health status. Article Snippet: For the DD data, we applied a Article Title: Preferences for oral anticoagulants in atrial fibrillation: a best-best discrete choice experiment. Article Snippet: Background Atrial fibrillation (AF) is recognised as a growing clinical and public health problem in many countries, owing to disability and death from stroke associated with the condition, high hospitalisation costs and an increasing prevalence with ageing populations.. Undertreatment with oral anticoagulants has been a significant challenge of treatment, historically related to patient concerns over the safety and convenience of warfarin, which until recently was the only oral anticoagulant available.. Objectives The aim of this study is to examine: (1) patient preferences for attributes of warfarin and the new oral anticoagulants (dabigatran, rivaroxaban, apixaban) in AF; (2) which attributes are most important; and (3) whether current under-treatment is likely to improve with the new oral anticoagulants. Article Title: From simple to even simpler, but not too simple: a head-to-head comparison of the Better-Worse and Drop-Down methods for measuring patient health status Article Snippet: For the DD data, we applied a |